205 related articles for article (PubMed ID: 29269805)
1. Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.
Mitrus I; Smagur A; Fidyk W; Czech M; Prokop M; Chwieduk A; Glowala-Kosinska M; Czerw T; Sobczyk-Kruszelnicka M; Mendrek W; Michalak K; Sadus-Wojciechowska M; Najda J; Holowiecki J; Giebel S
Bone Marrow Transplant; 2018 Mar; 53(3):274-280. PubMed ID: 29269805
[TBL] [Abstract][Full Text] [Related]
2. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
3. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation.
Smagur A; Mitrus I; Ciomber A; Panczyniak K; Fidyk W; Sadus-Wojciechowska M; Holowiecki J; Giebel S
Vox Sang; 2015 May; 108(4):417-24. PubMed ID: 25753814
[TBL] [Abstract][Full Text] [Related]
5. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
[TBL] [Abstract][Full Text] [Related]
6. Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies.
Bennett B; Hanotaux J; Pasala AR; Hasan T; Hassan D; Shor R; Allan DS; Maganti HB
Cytotherapy; 2024 May; 26(5):482-489. PubMed ID: 38416086
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
8. Long-term hematological reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5% and 10% dimethylsulfoxide at -80 degrees C in a mechanical freezer.
Galmes A; Gutiérrez A; Sampol A; Canaro M; Morey M; Iglesias J; Matamoros N; Duran MA; Novo A; Bea MD; Galán P; Balansat J; Martínez J; Bargay J; Besalduch J
Haematologica; 2007 Jul; 92(7):986-9. PubMed ID: 17606452
[TBL] [Abstract][Full Text] [Related]
9. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxide.
Trummer T; Fox R; Koç JR; de Lima M; Otegbeye F
Cytotherapy; 2020 Nov; 22(11):613-616. PubMed ID: 32600975
[TBL] [Abstract][Full Text] [Related]
11. Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.
Reich-Slotky R; Makhani SS; Vasovic LV; Pearse RN; Rossi A; Philips A; Cushing MM; Singh AD; van Besien K
Leuk Lymphoma; 2018 Dec; 59(12):2829-2835. PubMed ID: 29790808
[TBL] [Abstract][Full Text] [Related]
12. A faster reconstitution of hematopoiesis after autologous transplantation of hematopoietic cells cryopreserved in 7.5% dimethyl sulfoxide if compared to 10% dimethyl sulfoxide containing medium.
Mitrus I; Smagur A; Giebel S; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Sadus-Wojciechowska M; Tukiendorf A; Holowiecki J
Cryobiology; 2013 Dec; 67(3):327-31. PubMed ID: 24125911
[TBL] [Abstract][Full Text] [Related]
13. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
[TBL] [Abstract][Full Text] [Related]
14. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
[TBL] [Abstract][Full Text] [Related]
15. Use of cryoprotectant-depleted allogeneic peripheral blood stem cells for transplantation.
Hirata Y; Kishino K; Onozaki F; Nakaki Y; Fujiwara S; Yamamoto C; Sato K; Matsuyama T; Ozaki K; Mori M; Ozawa K; Muroi K
Hematology; 2011 Jul; 16(4):221-4. PubMed ID: 21756538
[TBL] [Abstract][Full Text] [Related]
16. Long term cryopreservation in 5% DMSO maintains unchanged CD34(+) cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation.
Abbruzzese L; Agostini F; Durante C; Toffola RT; Rupolo M; Rossi FM; Lleshi A; Zanolin S; Michieli M; Mazzucato M
Vox Sang; 2013 Jul; 105(1):77-80. PubMed ID: 23384290
[TBL] [Abstract][Full Text] [Related]
17. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO.
Lakota J; Fuchsberger P
Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035
[No Abstract] [Full Text] [Related]
18. Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a -80°C mechanical freezer and preserved less than 6 months.
Calvet L; Cabrespine A; Boiret-Dupré N; Merlin E; Paillard C; Berger M; Bay JO; Tournilhac O; Halle P
Transfusion; 2013 Mar; 53(3):570-8. PubMed ID: 22804351
[TBL] [Abstract][Full Text] [Related]
19. Pentaisomaltose, an Alternative to DMSO. Engraftment of Cryopreserved Human CD34
Svalgaard JD; Talkhoncheh MS; Haastrup EK; Munthe-Fog L; Clausen C; Hansen MB; Andersen P; Gørløv JS; Larsson J; Fischer-Nielsen A
Cell Transplant; 2018 Sep; 27(9):1407-1412. PubMed ID: 30056762
[TBL] [Abstract][Full Text] [Related]
20. Long-term engraftment stability of peripheral blood stem cells cryopreserved using the dump-freezing method in a -80 degrees C mechanical freezer with 10% dimethyl sulfoxide.
Choi CW; Kim BS; Seo JH; Shin SW; Kim YH; Kim JS
Int J Hematol; 2001 Feb; 73(2):245-50. PubMed ID: 11372739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
